Cargando…

Cost-effectiveness of CRAG-LFA screening for cryptococcal meningitis among people living with HIV in Uganda

BACKGROUND: Cryptococcal meningitis (CM) constitutes a significant source of mortality in resource-limited regions. Cryptococcal antigen (CRAG) can be detected in the blood before onset of meningitis. We sought to determine the cost-effectiveness of implementing CRAG screening using the recently dev...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ramachandran, Anu, Manabe, Yukari, Rajasingham, Radha, Shah, Maunank
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5364591/ https://www.ncbi.nlm.nih.gov/pubmed/28335769 http://dx.doi.org/10.1186/s12879-017-2325-9

Ejemplares similares

Cost-effectiveness analysis and budgetary impact of the Cryptococcal Antigen Lateral Flow Assay (CRAG-LFA) implementation for the screening and diagnosis of cryptococcosis in asymptomatic people living with HIV in Brazil
por: Vianna, Cid Manso de Mello, et al.
Publicado: (2021)

Cryptococcal Meningitis Treatment Strategies in Resource-Limited Settings: A Cost-Effectiveness Analysis
por: Rajasingham, Radha, et al.
Publicado: (2012)

A qualitative evaluation of an implementation study for cryptococcal antigen screening and treatment in Uganda
por: Lofgren, Sarah M., et al.
Publicado: (2018)

Nosocomial Drug-Resistant Bacteremia in 2 Cohorts with Cryptococcal Meningitis, Africa
por: Rajasingham, Radha, et al.
Publicado: (2014)

Induction-phase treatment costs for cryptococcal meningitis in high HIV-burden African countries: New opportunities with lower costs
por: Larson, Bruce, et al.
Publicado: (2022)

Routine Cryptococcal Antigen Screening in Solid Organ Transplant Recipients: Is it Time to Save Lives and Money?
por: George, Ige, et al.
Publicado: (2017)

Point-of-Care Lateral Flow Assays for Tuberculosis and Cryptococcal Antigenuria Predict Death in HIV Infected Adults in Uganda
por: Manabe, Yukari C., et al.
Publicado: (2014)

Hyponatremia as a Predictor of Cryptococcal Meningitis and Death Among Asymptomatic Persons With HIV and Cryptococcal Antigenemia
por: Lehman, Alice, et al.
Publicado: (2023)

Prevalence of cryptococcal antigen (CrAg) among HIV-positive patients in Eswatini, 2014–2015
por: Haumba, Samson M., et al.
Publicado: (2020)

Evaluation of a national cryptococcal antigen screening program for HIV-infected patients in Uganda: A cost-effectiveness modeling analysis
por: Rajasingham, Radha, et al.
Publicado: (2019)

Adherence of health workers to guidelines for screening and management of cryptococcal meningitis in Uganda
por: Namuju, Olivie C., et al.
Publicado: (2023)

Reflexive Laboratory-Based Cryptococcal Antigen Screening and Preemptive Fluconazole Therapy for Cryptococcal Antigenemia in HIV-Infected Individuals With CD4 <100 Cells/µL: A Stepped-Wedge, Cluster-Randomized Trial
por: Meya, David B., et al.
Publicado: (2019)

The Effect of Therapeutic Lumbar Punctures on Acute Mortality From Cryptococcal Meningitis
por: Rolfes, Melissa A., et al.
Publicado: (2014)

Using laboratory data to assess the impact of coronavirus (COVID-19) on reflex cryptococcal antigenaemia (CrAg) testing in South Africa
por: Cassim, Naseem, et al.
Publicado: (2023)

Correlation between Blood and CSF Compartment Cytokines and Chemokines in Subjects with Cryptococcal Meningitis
por: Okafor, Elizabeth C., et al.
Publicado: (2020)

Access to medicines for treating people with cryptococcal meningitis
por: Burry, Jessica, et al.
Publicado: (2023)

Cost-effectiveness of reflex laboratory-based cryptococcal antigen screening for the prevention and treatment of cryptococcal meningitis in Botswana
por: Tenforde, Mark W., et al.
Publicado: (2020)

Evaluation of the initial 12 months of a routine cryptococcal antigen screening program in reduction of HIV-associated cryptococcal meningitis in Uganda
por: Enock, Kagimu, et al.
Publicado: (2022)

Baseline Serum C-Reactive Protein Level Predicts Mortality in Cryptococcal Meningitis
por: Chesdachai, Supavit, et al.
Publicado: (2020)

Establishing a cost-per-result of laboratory-based, reflex Cryptococcal antigenaemia screening (CrAg) in HIV+ patients with CD4 counts less than 100 cells/μl using a Lateral Flow Assay (LFA) at a typical busy CD4 laboratory in South Africa
por: Cassim, Naseem, et al.
Publicado: (2017)

Cost Effectiveness of Cryptococcal Antigen Screening as a Strategy to Prevent HIV-Associated Cryptococcal Meningitis in South Africa
por: Jarvis, Joseph N., et al.
Publicado: (2013)

Delays in Cryptococcal Meningitis Diagnosis and Care: A Mixed Methods Study in Rural Uganda
por: Link, Abigail, et al.
Publicado: (2022)

Cerebrospinal Fluid Culture Positivity and Clinical Outcomes After Amphotericin-Based Induction Therapy for Cryptococcal Meningitis
por: Rolfes, Melissa A., et al.
Publicado: (2015)

The Changing Epidemiology of HIV-Associated Adult Meningitis, Uganda 2015–2017
por: Ellis, Jayne, et al.
Publicado: (2019)

Molecular mechanisms of cryptococcal meningitis
por: Liu, Tong-Bao, et al.
Publicado: (2012)

Cryptococcal meningitis complicating sarcoidosis
por: Leonhard, Sonja E., et al.
Publicado: (2016)

Crag Martin neontology complements taphonomy at the Gorham's Cave Complex
por: Bensusan, Keith, et al.
Publicado: (2021)

Long Term 5-Year Survival of Persons with Cryptococcal Meningitis or Asymptomatic Subclinical Antigenemia in Uganda
por: Butler, Elissa K., et al.
Publicado: (2012)

B Cell Compartmentalization in Blood and Cerebrospinal Fluid of HIV-Infected Ugandans with Cryptococcal Meningitis
por: Okurut, Samuel, et al.
Publicado: (2020)

Erratum to: The Changing Epidemiology of HIV-Associated Adult Meningitis, Uganda 2015–2017
por: Ellis, Jayne, et al.
Publicado: (2019)

Idiopathic CD4 Lymphocytopenia Presenting as Cryptococcal Meningitis
por: Shah, Preet Mukesh, et al.
Publicado: (2021)

Cryptococcal meningitis: epidemiology and therapeutic options
por: Sloan, Derek J, et al.
Publicado: (2014)

Hearing Loss in Cryptococcal Meningitis Survivors
por: Lofgren, Sarah, et al.
Publicado: (2017)

Treatment for HIV‐associated cryptococcal meningitis
por: Tenforde, Mark W, et al.
Publicado: (2018)

Cryptococcal meningitis: A neglected NTD?
por: Molloy, Síle F., et al.
Publicado: (2017)

Cryptococcal Meningitis in an Apparent Immunocompetent Patient
por: Poley, Marian, et al.
Publicado: (2019)

Microglia are not protective against cryptococcal meningitis
por: Mohamed, Sally H., et al.
Publicado: (2023)

Cryptococcal Meningitis in an Apparent Immunocompetent Host
por: Molina, Guarina, et al.
Publicado: (2023)

Connecting Cryptococcal Meningitis and Gut Microbiome
por: Ma, Yuanyuan, et al.
Publicado: (2023)

Climbing crags recommender system in Arco, Italy: a comparative study
por: Ivanova, Iustina, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_or02flln2advntmfgggnq8au5t